20 articles
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
Researchers compared stem cells from arthritis patients versus healthy donors to assess regenerative therapy potential.
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.
32-person trial compared bone marrow stem cells, platelet therapy, and hyaluronic acid for knee arthritis treatment over one year.
Small trial tests autologous stem cells to regenerate damaged knee cartilage in osteoarthritis patients with promising safety profile.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Large trial tests umbilical cord stem cells to prevent heart failure in heart attack patients with reduced heart function.
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
Clinical trial tested whether bone marrow stem cells could improve heart function beyond standard bypass surgery alone.
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
Researchers tested a novel stem cell therapy using umbilical cord cells on a pericardial matrix to repair heart tissue after heart attacks.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
Researchers tested injecting cardiac stem cells directly into heart arteries after heart attacks to promote healing and regeneration.
Researchers tested whether stem cells from healthy hearts could help repair damage in heart attack patients, offering hope for cardiac regeneration.
Austrian researchers tracked heart attack patients for 5 years after receiving bone marrow cell therapy to assess long-term cardiac outcomes.
115-patient trial tested CardioCell stem cell treatment against placebo for chronic heart failure patients with promising regenerative approach.
Completed study tested regenerative cardiac therapy in 105 heart attack patients, comparing stem cell treatment to placebo controls.
Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.
